Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA – MedCity News
Engineered viruses are a mainstay in genetic medicine due to their ability to ferry genetic cargo into cells. But limitations…
Tag: biopharma nl
This TechBio Startup Just Raised $2B Without Disclosing a Single Detail About Its Drugs – MedCity News
When a biotech startup reveals a substantial round of funding, the announcement typically includes information about a pipeline, or at…
Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain – MedCity News
Tortugas Neuroscience launched from stealth Tuesday with $106 million to support a pipeline of four in-licensed drugs in clinical development…
Startup Nula Emerges to Advance a New Class of Medicines for Metabolic Disease – MedCity News
In a cell, the nucleus and related genetic material are housed inside a double-layered membrane. Scientists previously thought this nuclear…
Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors – MedCity News
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Startup Waiv Spins Out of Owkin With $33M to Bring AI Precision to Cancer Decisions – MedCity News
Cancer treatment is evolving with a growing number of therapies designed to address specific targets expressed by tumors or genetic…
Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M – MedCity News
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies – MedCity News
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic – MedCity News
Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line…